A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
Public ClinicalTrials.gov record NCT04490057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.
Study identification
- NCT ID
- NCT04490057
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Interventions
- Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler Drug
- Varenicline or bupropion Drug
- Contingency Management Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2020
- Primary completion
- Oct 23, 2024
- Completion
- Oct 23, 2025
- Last update posted
- Jan 4, 2026
2020 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bridgeport Hospital Infectious Disease Clinic | Bridgeport | Connecticut | 06110 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| SUNY Downstate STAR Clinic | Brooklyn | New York | 11203 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Tobacco Use Cessation trials
Other public records listing Tobacco Use Cessation. Sorted by last update posted; newest first. Not a recommendation.
- NCT02162849: Reward Sensitivity and Pharmacotherapy for Smoking Cessation Active, not recruiting
- NCT07694492: Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid Not yet recruiting
- NCT07020273: CONNECT Cancer Survivors With Tobacco Treatment Active, not recruiting
- NCT07693660: VergeRx for Smokers Not Ready to Quit Not yet recruiting
- NCT05805722: Comprehensive Tobacco Cessation for Cancer Patients and Survivors Recruiting
- NCT05415761: Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04490057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04490057 live on ClinicalTrials.gov.